Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,071.63 +1.08 (+0.02%) Dow
38,460.92 -42.77 (-0.11%) Nasdaq
15,712.75 +16.11 (+0.10%) Bitcoin USD
64,282.21 -2,327.86 (-3.49%) CMC Crypto 200
1,387.76 -36.34 (-2.55%)
Berry Global Group, Inc. (0HN1.L)
| Previous close | 56.29 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 183 |
| Market cap | 66.735M |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | 0.10 |
| EPS (TTM) | 5.38 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksConstellium (CSTM) Misses Q1 Earnings Estimates
Constellium (CSTM) delivered earnings and revenue surprises of -55.56% and 10.08%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PR NewswireNewHold Enterprises Announces Sale of F&S Tool to Berry Global
NewHold Enterprises, an operationally focused investment firm, is pleased to announce the sale of F&S Tool, a leading North American designer and manufacturer of precision injection molding tools, to Berry Global Group, Inc. (NYSE: BERY). F&S Tool operates a 90,000 square foot facility located in Erie, Pennsylvania, with 11 issued/pending patents and 105 employees focused on proprietary technologies to serve a large and diverse addressable market. The sale was completed on April 05, 2024.
Business WireBerry and Glatfelter Announce Regulatory Milestone in Proposed Transaction for Spin-Off and Merger of Berry’s Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter
EVANSVILLE, Ind., April 17, 2024--Berry Global Group, Inc. (NYSE: BERY) and Glatfelter Corporation (NYSE: GLT) announced today the achievement of a regulatory milestone in the proposed transaction involving the combination of a majority of Berry’s Health, Hygiene and Specialties segment to include its Global Nonwovens and Films business ("HHNF") with Glatfelter, with the expiration of the required waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act.
